Cadence Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of Goods Sold | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 15.4 | 13.6 | 14.4 | 13.5 | 15.5 |
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 |
| Operating Income | (15.6) | (13.8) | (14.6) | (13.6) | (15.7) |
| Operating Margin | -- | -- | -- | -- | -- |
| Nonoperating Income | 0.5 | 0.6 | 0.6 | 0.8 | 0.9 |
| Nonoperating Expenses | 0.5 | 0.5 | 0.3 | 0.2 | 0.2 |
| Income Before Taxes | (15.6) | (13.7) | (14.2) | (13.0) | (14.9) |
| Income Taxes | -- | -- | -- | -- | -- |
| Net Income After Taxes | (15.6) | (13.7) | (14.2) | (13.0) | (14.9) |
| Continuing Operations | (15.6) | (13.7) | (14.2) | (13.0) | (14.9) |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | (15.6) | (13.7) | (14.2) | (13.0) | (14.9) |
| Total Net Income | (15.6) | (13.7) | (14.2) | (13.0) | (14.9) |
| Net Profit Margin | -- | -- | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.41) | (0.42) | (0.50) | (0.45) | (0.52) |
| Dividends per Share | -- | -- | -- | -- | -- |
This data is provided as per license from EDGAR Online
